{"id":"https://openalex.org/W2805905162","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.552","title":"Estimation of historical control rate for a single arm de-escalation study: Application to the POSITIVE trial.","display_name":"Estimation of historical control rate for a single arm de-escalation study: Application to the POSITIVE trial.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2805905162","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.552","mag":"2805905162"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.552","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.552","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.552","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105415166","display_name":"Zhuoxin Sun","orcid":"https://orcid.org/0000-0002-7428-534X","observed_orcids":["https://orcid.org/0000-0002-7428-534X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhuoxin Sun","raw_affiliation_strings":["IBCSG Statistical Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IBCSG Statistical Center, Boston, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070351685","display_name":"Olivia Pagani","orcid":"https://orcid.org/0000-0001-9739-6299","observed_orcids":["https://orcid.org/0000-0001-9739-6299"]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Olivia Pagani","raw_affiliation_strings":["Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Oncology of Southern Switzerland, Lugano Viganello, Switzerland;","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039694693","display_name":"Ann H. Partridge","orcid":"https://orcid.org/0000-0002-4722-4824","observed_orcids":["https://orcid.org/0000-0002-4722-4824"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann H. Partridge","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032252442","display_name":"Hatem A. Azim","orcid":"https://orcid.org/0000-0003-4865-3193","observed_orcids":["https://orcid.org/0000-0003-4865-3193"]},"institutions":[{"id":"https://openalex.org/I98635879","display_name":"American University of Beirut","ror":"https://ror.org/04pznsd21","country_code":"LB","type":"education","lineage":["https://openalex.org/I98635879"]}],"countries":["LB"],"is_corresponding":false,"raw_author_name":"Hatem A. Azim","raw_affiliation_strings":["American University of Beirut, Department of Internal Medicine, Division of Hematology Oncology, Beruit, Lebanon;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American University of Beirut, Department of Internal Medicine, Division of Hematology Oncology, Beruit, Lebanon;","institution_ids":["https://openalex.org/I98635879"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007007404","display_name":"Fedro Alessandro Peccatori","orcid":"https://orcid.org/0000-0001-8227-8740","observed_orcids":["https://orcid.org/0000-0001-8227-8740"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fedro Peccatori","raw_affiliation_strings":["Istituto Europeo di Oncologia, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Europeo di Oncologia, Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102934623","display_name":"Monica Ruggeri","orcid":"https://orcid.org/0000-0002-9025-0745","observed_orcids":["https://orcid.org/0000-0002-9025-0745"]},"institutions":[{"id":"https://openalex.org/I4210155995","display_name":"International Breast Cancer Study Group","ror":"https://ror.org/05b2gms10","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210155995"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Monica Ruggeri","raw_affiliation_strings":["International Breast Cancer Study Group (IBCSG), Bern, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Breast Cancer Study Group (IBCSG), Bern, Switzerland;","institution_ids":["https://openalex.org/I4210155995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053376791","display_name":"Marco Angelo Colleoni","orcid":"https://orcid.org/0000-0002-5743-3013","observed_orcids":["https://orcid.org/0000-0002-5743-3013","https://orcid.org/0000-0003-1925-2139"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marco Colleoni","raw_affiliation_strings":["European Institute of Oncology, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"European Institute of Oncology, Milan, Italy;","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040290360","display_name":"Richard D. Gelber","orcid":"https://orcid.org/0000-0001-8270-8712","observed_orcids":["https://orcid.org/0000-0001-8270-8712"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210138586","display_name":"Frontier Science & Technology Research Foundation, Inc.","ror":"https://ror.org/04hbhf775","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210138586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard D. Gelber","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, and Frontier Science and Technology Research Foundation, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, and Frontier Science and Technology Research Foundation, Boston, MA;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210138586"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017334876","display_name":"Meredith M. Regan","orcid":"https://orcid.org/0000-0002-2428-6109","observed_orcids":["https://orcid.org/0000-0002-2428-6109"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meredith M. Regan","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"552","last_page":"552"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.04050000011920929,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14374","display_name":"Statistical Methods in Epidemiology","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/de-escalation","display_name":"de-escalation","score":0.7559999823570251},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.7139999866485596},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.8019999861717224},{"id":"https://openalex.org/keywords/breast-cancer-recurrence","display_name":"breast cancer recurrence","score":0.8989999890327454},{"id":"https://openalex.org/keywords/piecewise-exponential-model","display_name":"piecewise exponential model","score":0.7929999828338623},{"id":"https://openalex.org/keywords/propensity-score-matching","display_name":"propensity score matching","score":0.6579999923706055},{"id":"https://openalex.org/keywords/clinical-trial-monitoring","display_name":"clinical trial monitoring","score":0.7059999704360962},{"id":"https://openalex.org/keywords/breast-cancer-in-young-women","display_name":"young women with breast cancer","score":0.6830000281333923},{"id":"https://openalex.org/keywords/pregnancy-after-cancer","display_name":"pregnancy after cancer treatment","score":0.7519999742507935}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8427048921585083},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6397542953491211},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5474392771720886},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4535943865776062},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.44210484623908997},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4390975534915924},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.425332248210907},{"id":"https://openalex.org/C122048520","wikidata":"https://www.wikidata.org/wiki/Q2913954","display_name":"Percentile","level":2,"score":0.4213227927684784},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40852564573287964},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3468424081802368},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3327562212944031},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.32605576515197754},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.32095223665237427},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.31676357984542847},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.21525371074676514},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.552","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.552","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.552","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6921100940","https://openalex.org/W1509148667","https://openalex.org/W3172450629","https://openalex.org/W7073579336","https://openalex.org/W7162794027","https://openalex.org/W6959028069","https://openalex.org/W6958717172","https://openalex.org/W2980497127","https://openalex.org/W7162639576","https://openalex.org/W4205535987"],"abstract_inverted_index":{"552":[0],"Background:":[1],"A":[2],"randomized,":[3],"controlled":[4],"clinical":[5],"trial":[6,23,276,302],"is":[7,29,34,77,110],"the":[8,13,99,136,163,219,232,255,264,287],"optimal":[9],"method":[10],"to":[11,69,88,139,166,170,185,252,293,320],"evaluate":[12],"effect":[14],"of":[15,63,75,81,83,108,126,175,263,286,326],"an":[16,327],"experimental":[17],"therapy.":[18],"However":[19],"a":[20,35,90,124,147,298,322],"single":[21,37],"arm":[22],"can":[24],"be":[25,309],"used":[26,282],"when":[27],"randomization":[28],"infeasible":[30],"or":[31],"unethical.":[32],"POSITIVE":[33,95,109,130,171,193,224,235,288],"prospective,":[36],"arm,":[38],"international":[39],"study":[40,289],"aimed":[41],"at":[42,115],"young":[43],"(age":[44],"18-42)":[45],"women":[46],"with":[47,181,192],"endocrine":[48,65],"responsive":[49],"(ER+)":[50],"breast":[51,111],"cancer":[52,112],"(BC)":[53],"who":[54],"desire":[55],"pregnancy.":[56],"It":[57],"will":[58],"assess":[59],"whether":[60],"temporary":[61],"interruption":[62],"adjuvant":[64],"therapy":[66],"(for":[67],"up":[68],"2":[70],"yrs)":[71],"after":[72],"18-30":[73],"months":[74],"use":[76],"safe":[78],"in":[79,291],"terms":[80],"risk":[82],"recurrence.":[84],"We":[85],"describe":[86],"methods":[87,281,305],"estimate":[89,325],"historical":[91,328],"control":[92,220,329],"rate":[93,155,330,337,343],"for":[94,218,254,301],"using":[96,311],"data":[97,312],"from":[98,313],"SOFT/TEXT":[100,127,137,164,168,176,229],"Phase":[101],"3":[102,116,141,152,197,203,270,340],"trials.":[103],"Methods:":[104],"The":[105,195,280,304],"primary":[106],"endpoint":[107],"recurrence":[113],"(BCR)":[114],"yrs.":[117],"In":[118],"this":[119],"analysis,":[120],"we":[121],"first":[122],"identified":[123],"cohort":[125,138,165],"pts":[128,169,177,225,230,236],"meeting":[129],"eligibility":[131,233],"criteria.":[132,234],"Method":[133,160,247,250,346,354],"I":[134,251,347],"uses":[135,162],"calculate":[140],"yr":[142,153,198,204,271,341],"annualized":[143,199,265],"hazard":[144,200,267,336],"rates":[145,201,268,273],"by":[146,156],"piecewise":[148],"exponential":[149],"model":[150],"and":[151,202,208,211,243,258,269,290,307],"BCR":[154,206,266,272,335,342],"Kaplan-Meier":[157],"(KM)":[158],"estimate.":[159],"II":[161,248,355],"group-match":[167],"pts;":[172],"sample":[173],"sets":[174,187],"were":[178,214,226,237],"randomly":[179],"drawn":[180],"replacement":[182],"5000":[183],"times":[184],"obtain":[186],"having":[188],"baseline":[189,284],"characteristics":[190,257,285],"well-balanced":[191],"pts.":[194],"mean":[196],"KM":[205],"rates,":[207],"their":[209],"2.5th":[210],"97.5th":[212],"percentiles,":[213],"estimates":[215,262],"(95%":[216],"CI)":[217],"group.":[221],"Results:":[222],"149":[223],"included;":[227],"1499":[228],"met":[231],"younger,":[238],"had":[239],"fewer":[240,244],"positive":[241],"nodes,":[242],"received":[245],"chemotherapy.":[246],"refines":[249],"adjust":[253],"imbalanced":[256],"provides":[259],"more":[260],"precise":[261],"(Table).":[274],"Clinical":[275],"information:":[277],"NCT02308085.":[278],"Conclusions:":[279],"only":[283],"addition":[292],"final":[294],"analysis":[295],"interpretation,":[296],"have":[297],"potential":[299],"role":[300],"monitoring.":[303],"should,":[306],"will,":[308],"applied":[310],"other":[314],"sources":[315],"(e.g.":[316],"ABCSG-12,":[317],"ASCO":[318],"CancerLinQ)":[319],"assure":[321],"consistent,":[323],"robust":[324],"across":[331],"different":[332],"cohorts.":[333],"Annualized":[334],"95%":[338,344],"CI":[339,345],"3.4%":[348],"2.8%,":[349],"4.0%":[350],"9.5%":[351],"7.9%,":[352],"11.1%":[353],"3.1%":[356],"2.6%,":[357],"3.7%":[358],"8.7%":[359],"7.2%,":[360],"10.3%":[361]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2018-06-13T00:00:00"}